Hyperoxia for sepsis and development of acute lung injury with increased mortality.
Ryo YamamotoSeitaro FujishimaKazuma YamakawaToshikazu AbeHiroshi OguraDaizoh SaitohSatoshi GandoJunichi SasakiPublished in: BMJ open respiratory research (2023)
University Hospital Medical Information Network Clinical Trial Registry (UMIN000027452).
Keyphrases
- clinical trial
- lipopolysaccharide induced
- lps induced
- healthcare
- acute kidney injury
- cardiovascular events
- intensive care unit
- septic shock
- phase ii
- study protocol
- risk factors
- inflammatory response
- double blind
- cardiovascular disease
- type diabetes
- randomized controlled trial
- phase iii
- coronary artery disease
- placebo controlled